Southern Acids (malaysia) Bhd. · MYX:SAB

Southern Acids (malaysia) Bhd — Southern Acids (M) Berhad — Shareholder Meeting (August 2019)

16 slides from Southern Acids (malaysia) Bhd's shareholder meeting presentation, Aug 30, 2019

  1. Slide 1: Southern Acids (M) Berhad 38th Annual General Meeting Shareholders Briefing

    SOUTHERN ACIDS (M) BERHAD 38TH ANNUAL GENERAL MEETING 30 AUGUST 2019 SHAREHOLDERS BRIEFING 30 August 2019 1

  2. Slide 2: Shareholders Briefing Information

    Shareholders Briefing Information This information contained in this briefing are mainly derived from the following:-  The Company’s 2019 Annual Report; and  All other information that are available from Bursa Malaysia Securities Berhad’s website. 30 August 2019 2

  3. Slide 3: Presentation Contents

    Presentation Contents 1. Southern Acids (M) Berhad (“SAB or the Company”) & Its Subsidiaries (“SAB Group”) a. SAB Group’s Key Financial Highlights For The Financial Year Ended 31 March 2019 (“FY2019”); and b. SAB Group’s Financial Performance For The FY2019 2. SAB Group’s Segments a. Review Of The R

  4. Slide 4: SAB Group's Key Financial Highlights for FY2019

    SOUTHERN ACIDS (M) BERHAD SAB GROUP’S KEY FINANCIAL HIGHLIGHTS FOR FY2019 30 August 2019 4

  5. Slide 5: Key Financial Highlights: Revenue, PBT, Profit for the Year

    SOUTHERN ACIDS (M) BEHAD - KEY FINANCIAL HIGHLIGHTS FY2018 FY2019 (RM’000) (RM’000) Restated Changes Revenue 598,645 763,104 (21.6%) Profit Before Tax (“PBT”) 38,574 51,019 (24.4%) Profit For The Year 25,468 37,039 (31.2%) Earnings Per Share 15.69 sen 23.78 sen (34.0%) Dividend (Net) 5.0 sen 5.0 sen

  6. Slide 6: Key Financial Highlights: Total Assets, Liabilities, Equity

    SOUTHERN ACIDS (M) BEHAD - KEY FINANCIAL HIGHLIGHTS FY2018 FY2019 (RM’000) (RM’000) Restated Changes Total Assets 731,557 717,050 2.0% Total Liabilities 75,542 79,981 (5.6%) Equity Attributable To 601,281 586,376 2.5% Shareholders Of The Company 30 August 2019 6

  7. Slide 7: SAB Group's Financial Performance

    SAB Group’s Financial Performance FY2019 FY2018 Changes Change RM’000 RM’000 RM’000 s Restated % Group’s Revenue 598,645 763,104 164,459 (21.6%) Group’s PBT 38,574 51,019 (12,445) (24.4%) Factors For The Decrease In PBT 1. Losses (instead of a profit) incurred by Oleochemical Segment 2. Lower contri

  8. Slide 8: Review of the Respective Group Segments' Financial Performance

    SOUTHERN ACIDS (M) BEHAD Review Of The Respective Group Segments’ Financial Performance 30 August 2019 8

  9. Slide 9: Oleochemical Segment - Financial Performance

    Oleochemical Segment - Financial Performance FY2019 FY2018 Changes Changes RM’000 RM’000 RM’000 % Restated Revenue 290,651 383,869 (93,218) (24.3%) (Loss Before Tax) / PBT (2,445) 5,905 (8,350) (141.4%) Main factors for the decrease in PBT 1. Sales volume was lower by 12.7% to 82,114 MT, the lowest

  10. Slide 10: Oleochemical Segment - Outlook For FY2020

    Oleochemical Segment - Outlook For FY2020 Challenging, key factors are as follows:- 1. External factors;  Keen competition as well as competing with competitors with better cost advantage  Volatility in USD/MYR exchange rates. 2. Internal factors;  Our ageing plant conditions  Increasing trend o

  11. Slide 11: Milling & Estate Segment - Financial Performance

    Milling & Estate Segment - Financial Performance FY2019 FY2018 Changes Changes RM’000 RM’000 RM’000 % Restated Revenue 205,796 275,802 (70,006) (25.4%) PBT 16,628 20,087 (3,459) (17.2%) Main factors for the decrease in PBT 1. Lower average selling price (“ASP”) of both crude palm oil (“CPO”) (19.9%)

  12. Slide 12: Milling & Estate Segment - Outlook For FY2020

    Milling & Estate Segment - Outlook For FY2020 Challenging, the performance of this segment is largely subject to the following uncontrollable factors:- 1. External factors;  CPO price outlook  External Fresh Fruit Bunches (“FFB”), the purchase price and quantity 2. Internal factors;  FFB producti

  13. Slide 13: Healthcare Segment - Financial Performance

    Healthcare Segment - Financial Performance FY2019 FY2018 Changes Changes RM’000 RM’000 RM’000 % Restated Revenue 84,216 84,716 (500) (0.6%) PBT 22,997 21,992 1,005 4.6% Factor for the increase in PBT 1. It was mainly contributed by higher interest income 30 August 2019 13

  14. Slide 14: Healthcare Segment - Outlook For FY2020

    Healthcare Segment - Outlook For FY2020 Continue to enjoy stable growth, driven by the following factors:- 1. External factors;  Healthcare sector’s earnings is expected to remain resilient 2. Internal factors;  The new and improved cancer center is expected to be commissioning by September 2019 

  15. Slide 15: SAB Group - Outlook For FY2020

    SAB Group - Outlook For FY2020 In short, it remains challenging. 30 August 2019 15

  16. Slide 16: Questions & Answers

    SOUTHERN ACIDS (M) BERHAD Questions & Answers 30 August 2019 16

Southern Acids (M) Berhad — Shareholder Meeting (August 2019) on 6ix